• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗疟化合物中的正电荷开启广谱抗菌活性。

Positive Charge in an Antimalarial Compound Unlocks Broad-Spectrum Antibacterial Activity.

作者信息

Braun-Cornejo Maria, Platteschorre Mitchell, de Vries Vincent, Bravo Patricia, Sonawane Vidhisha, Hamed Mostafa M, Haupenthal Jörg, Reiling Norbert, Rottmann Matthias, Piet Dennis, Maas Peter, Diamanti Eleonora, Hirsch Anna K H

机构信息

Specs Compound Handling, B.V., Bleiswijkseweg 55, Zoetermeer 2712 PB, The Netherlands.

Department of Pharmacy, Saarland University, Campus Building E8.1, Saarbrücken 66123, Germany.

出版信息

JACS Au. 2025 Feb 21;5(3):1146-1156. doi: 10.1021/jacsau.4c00935. eCollection 2025 Mar 24.

DOI:10.1021/jacsau.4c00935
PMID:40151263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11938010/
Abstract

In this study, we synthesized a library of eNTRy-rule-compliant compounds by introducing ionizable nitrogen atoms to an antimalarial compound. These positively charged derivatives gained activity against both Gram-negative and -positive bacteria, , and boosted inhibition to the double-digit nanomolar range. Overcoming and remaining inside the cell envelope of Gram-negative bacteria (GNB) is one of the major difficulties in antibacterial drug discovery and development. The eNTRy rules (N = ionizable nitrogen, T = low three-dimensionality, R = rigidity) can be a useful structural guideline to improve accumulation of small molecules in GNB. With the aim of unlocking Gram-negative activity, we added amines and (cyclic) -alkyl guanidines to an already flat and rigid pyrazole-amide class as a representative example for our investigation. To test their performance, we compared these eNTRy-rule-compliant compounds to closely related noncompliant ones through phenotypic screening of various pathogens (, , , , , , and ), obtaining a handful of broad-spectrum hits. The results support the working hypothesis and even extend its applicability. The studied pyrazole-amide class adheres to the eNTRy rules; noncompliant compounds do not kill any of the bacteria tested, while compliant compounds largely showed growth inhibition of Gram-negative, -positive, and bacteria in the single-digit micromolar range.

摘要

在本研究中,我们通过将可电离氮原子引入一种抗疟化合物,合成了一系列符合eNTRy规则的化合物。这些带正电荷的衍生物对革兰氏阴性菌和革兰氏阳性菌均具有活性,并将抑制作用提高到两位数的纳摩尔范围。克服并滞留在革兰氏阴性菌(GNB)的细胞包膜内是抗菌药物发现和开发中的主要困难之一。eNTRy规则(N = 可电离氮,T = 低三维性,R = 刚性)可作为提高小分子在GNB中积累的有用结构指导。为了开启革兰氏阴性菌活性,我们将胺类和(环状)烷基胍添加到一个已经扁平且刚性的吡唑酰胺类化合物中,作为我们研究的一个代表性例子。为了测试它们的性能,我们通过对各种病原体(、、、、、和)进行表型筛选,将这些符合eNTRy规则的化合物与密切相关的不符合规则的化合物进行比较,获得了一些广谱活性化合物。结果支持了工作假设,甚至扩展了其适用性。所研究的吡唑酰胺类化合物符合eNTRy规则;不符合规则的化合物对任何测试细菌均无杀灭作用,而符合规则的化合物在个位数微摩尔范围内对革兰氏阴性菌、革兰氏阳性菌和细菌大多表现出生长抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/c7adde0076e8/au4c00935_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/cd95235ccc1b/au4c00935_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/30df9cfe03c9/au4c00935_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/6f62f56d164d/au4c00935_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/55bf631eda06/au4c00935_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/5399a4aa17f7/au4c00935_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/be0f5bb3e259/au4c00935_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/c7adde0076e8/au4c00935_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/cd95235ccc1b/au4c00935_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/30df9cfe03c9/au4c00935_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/6f62f56d164d/au4c00935_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/55bf631eda06/au4c00935_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/5399a4aa17f7/au4c00935_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/be0f5bb3e259/au4c00935_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a28/11938010/c7adde0076e8/au4c00935_0004.jpg

相似文献

1
Positive Charge in an Antimalarial Compound Unlocks Broad-Spectrum Antibacterial Activity.抗疟化合物中的正电荷开启广谱抗菌活性。
JACS Au. 2025 Feb 21;5(3):1146-1156. doi: 10.1021/jacsau.4c00935. eCollection 2025 Mar 24.
2
Facilitating Compound Entry as a Means to Discover Antibiotics for Gram-Negative Bacteria.促进化合物进入以发现针对革兰氏阴性菌的抗生素。
Acc Chem Res. 2021 Mar 16;54(6):1322-1333. doi: 10.1021/acs.accounts.0c00895. Epub 2021 Feb 26.
3
Fragment-Based Whole Cell Screen Delivers Hits against M. tuberculosis and Non-tuberculous Mycobacteria.基于片段的全细胞筛选获得针对结核分枝杆菌和非结核分枝杆菌的活性化合物。
Front Microbiol. 2016 Sep 7;7:1392. doi: 10.3389/fmicb.2016.01392. eCollection 2016.
4
The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.将仅针对革兰氏阳性菌的化合物转化为广谱抗生素面临的挑战。
Ann N Y Acad Sci. 2019 Jan;1435(1):18-38. doi: 10.1111/nyas.13598. Epub 2018 Feb 15.
5
SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria.苯并咪唑类衍生物作为抗革兰氏阴性菌抗菌剂的 SAR 研究与优化。
Eur J Med Chem. 2023 Feb 5;247:115040. doi: 10.1016/j.ejmech.2022.115040. Epub 2022 Dec 22.
6
Fluorescence High-Throughput Screening for Inhibitors of TonB Action.用于TonB作用抑制剂的荧光高通量筛选
J Bacteriol. 2017 Apr 25;199(10). doi: 10.1128/JB.00889-16. Print 2017 May 15.
7
[The history of the development and changes of quinolone antibacterial agents].[喹诺酮类抗菌药物的发展与变迁史]
Yakushigaku Zasshi. 2003;38(2):161-79.
8
Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.具有高选择性和广谱抗菌活性的膜活性氨基酸偶联聚醚胺衍生物。
Acta Biomater. 2022 Apr 1;142:136-148. doi: 10.1016/j.actbio.2022.02.009. Epub 2022 Feb 11.
9
Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.设计、筛选和鉴定具有抗革兰氏阴性菌胞外抗菌活性的工程噬菌体溶菌素。
Appl Environ Microbiol. 2023 Jul 26;89(7):e0058123. doi: 10.1128/aem.00581-23. Epub 2023 Jun 20.
10
[Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].[9年烧伤患者病原菌分布及耐药性分析]
Zhonghua Shao Shang Za Zhi. 2018 Mar 20;34(3):153-159. doi: 10.3760/cma.j.issn.1009-2587.2018.03.008.

本文引用的文献

1
Guiding the Way: Traditional Medicinal Chemistry Inspiration for Rational Gram-Negative Drug Design.引路前行:传统药物化学对合理设计抗革兰氏阴性菌药物的启示
J Med Chem. 2024 Jan 11;67(1):65-80. doi: 10.1021/acs.jmedchem.3c01831. Epub 2023 Dec 22.
2
Exploring the Translational Gap of a Novel Class of Escherichia coli IspE Inhibitors.探索新型大肠杆菌 IspE 抑制剂的转化差距。
ChemMedChem. 2023 Oct 4;18(19):e202300346. doi: 10.1002/cmdc.202300346. Epub 2023 Sep 28.
3
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials.
对抗抗生素耐药性——寻找新抗菌药物的策略和(临床前)研发。
EMBO Rep. 2023 Jan 9;24(1):e56033. doi: 10.15252/embr.202256033. Epub 2022 Dec 19.
4
Structure-Uptake Relationship Studies of Oxazolidinones in Gram-Negative ESKAPE Pathogens.唑烷酮类药物在革兰氏阴性 ESKAPE 病原体中的结构摄取关系研究。
J Med Chem. 2022 Oct 27;65(20):14144-14179. doi: 10.1021/acs.jmedchem.2c01349. Epub 2022 Oct 18.
5
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with Efficacy against Drug-Resistant Gram-Negative Infections.一种迭代方法指导发现法比霉素(FabI抑制剂),这是一种后期抗生素候选药物,对耐药革兰氏阴性菌感染有效。
ACS Cent Sci. 2022 Aug 24;8(8):1145-1158. doi: 10.1021/acscentsci.2c00598. Epub 2022 Aug 10.
6
CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection.CpxA 磷酸酶抑制剂激活 CpxRA,有望成为尿路感染大肠杆菌感染小鼠模型的潜在治疗方法。
Microbiol Spectr. 2022 Apr 27;10(2):e0243021. doi: 10.1128/spectrum.02430-21. Epub 2022 Mar 17.
7
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
8
Synthesis and Structure-Activity Relationships of New 2-Phenoxybenzamides with Antiplasmodial Activity.具有抗疟活性的新型2-苯氧基苯甲酰胺的合成及其构效关系
Pharmaceuticals (Basel). 2021 Oct 30;14(11):1109. doi: 10.3390/ph14111109.
9
Assessment of the rules related to gaining activity against Gram-negative bacteria.评估与获得抗革兰氏阴性菌活性相关的规则。
RSC Med Chem. 2021 Mar 3;12(4):593-601. doi: 10.1039/d0md00409j. eCollection 2021 Apr 28.
10
"Photo-Rimonabant": Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar "-On" CBR Antagonist.“光瑞莫那班”:新型光致变色瑞莫那班类似物的合成与生物评价,得到一个高选择性和纳摩尔级的“开”型 CB1 拮抗剂。
ACS Chem Neurosci. 2021 May 5;12(9):1632-1647. doi: 10.1021/acschemneuro.1c00086. Epub 2021 Apr 15.